MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Stem cells. See also Human embryonic stem cells"

  • 2017 International Congress

    Genetic and pharmacological rescue of DJ-1 loss-of-function caused by a c.192G>C mutation in PARK7

    I. Boussaad, C. Obermaier, Z. Hanss, N. Weisschuh, B. Schmid, S. Hoffmann, L. Burbulla, C. Klein, S. Duga, D. Krainc, T.G. Gasser, B. Wissinger, R. Krüger (Esch-sur-Alzette, Luxembourg)

    Objective: In this study we investigate the cellular mechanism underlying the Parkinson’s disease (PD)-associated mutation c.192G>C in PARK7 and present a compound treatment that rescues…
  • 2016 International Congress

    A descriptive study on the safety and feasibility of mesenchymal stem cell therapy for Parkinson’s disease: A case series

    M.J.O.V. Buensalido, J.J.A. Tiongson (Pasig City, Philippines)

    Objective: To describe the incidence and severity of infusion-related adverse events of mesenchymal stem cells (MSC) for Parkinson's disease in patients who underwent treatment. Background:…
  • 2016 International Congress

    Two-step induction of dopaminergic neurons – Differentiation of leukapharesis-derived mesenchymal stem cells

    S.I. El-Jaafary, M.M. Abdel-Dayem, N.M. Salama, H. Gabr, A.S. Abdelhafiz, Z.M. Ismail (Cairo, Egypt)

    Objective: The aim of the present study is to establish a reproducible in-vitro protocol to induce the human MSCs derived from peripheral blood, after mobilization…
  • 2016 International Congress

    Differentiated versus undifferentiated mesenchymal stem cell therapy in paraquat model of Parkinson’s disease

    S.I. El-Jaafary, H.S. Abdel Tawab, M.Y. Elwash, H. Gabr, H.M. Saad Eldien (Cairo, Egypt)

    Objective: To investigate the effect of undifferentiated versus differentiated CD34 stem cells series on paraquat model of PD and to elucidate the mechanism of action…
  • 2016 International Congress

    Generation of dopaminergic neurons for studying Parkinson’s disease using patient blood cells

    D. Ma, W. Zhou, Y. Chao, Y. Zhao, E.K. Tan (Singapore, Singapore)

    Objective: To study the molecular mechanism of G2385R mutation of LRRK2 gene in PD developing, dopaminergic neurons are derived from patient specific induced pluripotent stem…
  • 2016 International Congress

    Generation and characterization of midbrain organoids from iPSCs of familial Parkinson’s disease

    E. Frattini, G. Monzio Compagnoni, S. Salani, P. Rinchetti, M. Nizzardo, M. Baccarin, N. Bresolin, G.P. Comi, S.P. Corti, A. Di Fonzo (Milan, Italy)

    Objective: To generate and characterize human pluripotent stem cell (iPSCs) - derived midbrain cerebral organoids of patients with Parkinson's disease. Background: Parkinson's disease is a…
  • 2016 International Congress

    Altered glutamate response and calcium dynamics in iPSC derived striatal neurons from XDP-patients

    P. Capetian, N. Stanslowsky, E.M. Bernhardi, M. Naujock, K. Grütz, A. Domingo, P. Seibler, F. Wegner, C. Klein (Lübeck, Germany)

    Objective: Our objective was to generate an in vitro model of XDP based on striatal neurons differentiated from induced pluripotent stem cells (iPSC), followed by…
  • 2016 International Congress

    Modeling dementia with Lewy bodies using patient-derived neurons

    D.H. Adamowicz, J. Mertens, D.P. Salmon, D.R. Galasko, S. Roy, F.H. Gage (La Jolla, CA, USA)

    Objective: To model Dementia with Lewy bodies (DLB) using neurons derived from patients clinically diagnosed with the disease. Background: A major challenge in neurodegenerative disease…
  • 2016 International Congress

    The potential therapeutic effect of intranasal administration of stem cells in rotenone model of Parkinson’s disease in mice

    M. El-Gamal, M. Salama, M. Sobh, M. Emam, A. Abdalla, A. Lotfy, D. Sabry, M. El-Qotb, M. Sobh (Mansoura, Egypt)

    Objective: In this study we assessed the potential beneficial effect of intranasal administration of mesenchymal stem cells (MSCs) to rotenone model of PD in C57bl/6…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley